Professor, Department of Medicine
Harvard Medical School, Adult Oncology
Dana-Farber Cancer Institute
Dr. Johnson is a lung clinician/researcher who is interested in developing and testing new targeted therapies to treat lung cancer. He also examines the differences between patients who respond to a particular treatment and those that do not fare as well. In the interview he discusses his research and the value of clinical trials to the drug discovery process.
Interview Questions
About Dr. Johnson
(時間:
11sec
)
Research Motivations
(時間:
34sec
)
Targeted Versus Chemotherapy
(時間:
1min
52sec
)
Research Focus
(時間:
1min
17sec
)
Design Patient Treatment
(時間:
1min
6sec
)
Model Systems
(時間:
1min
27sec
)
Personalized Medicine
(時間:
2min
28sec
)
Cancer Genome Atlas
(時間:
3min
16sec
)
Research Limitations
(時間:
1min
57sec
)
Clinical Trials
(時間:
3min
10sec
)
Advice For Students
(時間:
1min
41sec
)
頂部